USA - NASDAQ:APYX - US03837C1062 - Common Stock
Overall APYX gets a fundamental rating of 2 out of 10. We evaluated APYX against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of APYX have multiple concerns. APYX is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -29.66% | ||
ROE | -237.96% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 61.63% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.74 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.72 | ||
Quick Ratio | 3.95 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:APYX (10/23/2025, 4:30:01 PM)
2.9
-0.13 (-4.29%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 2.36 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 15.12 | ||
P/tB | 15.12 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -29.66% | ||
ROE | -237.96% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 61.63% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.74 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 129.14% | ||
Cap/Sales | 1.54% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.72 | ||
Quick Ratio | 3.95 | ||
Altman-Z | 0.2 |